Endometrioid Carcinoma Symptoms: Early Detection and Diagnostic Insights
Written by Dr. Anjali Sharma, MD | Medically Reviewed by Dr. Rajesh Kumar, MD | Last Updated:
At a Glance
- Sample Required: Endometrial biopsy or blood for genetic testing (if indicated)
- Fasting Rules: No fasting required for biopsy; fasting may be required for blood tests (as per lab instructions)
- Turnaround Time (TAT): Biopsy: 5-7 days; Genetic testing: 2-4 weeks
- Base Cost: [Insert Current 2026 Price]
Understanding Endometrioid Carcinoma
Endometrioid carcinoma is the most common subtype of endometrial cancer, arising from the glandular lining of the uterus (endometrium). It is often hormone-sensitive and may be associated with unopposed estrogen exposure. In India, the incidence is rising, making awareness and early detection critical.
Clinical Presentation: Recognizing Symptoms
Symptoms can be subtle, but persistent changes warrant medical evaluation. The most common symptom is abnormal uterine bleeding, particularly postmenopausal bleeding. Other symptoms may include pelvic pain, vaginal discharge, and urinary symptoms.
| Symptom | Description | When to Seek Care |
|---|---|---|
| Abnormal vaginal bleeding | Bleeding between periods, heavy menstrual flow, or any bleeding after menopause | Immediately if postmenopausal; within 2 weeks if persistent |
| Pelvic pain or cramping | Pain in the lower abdomen, often during or after intercourse | If persistent for more than 2 weeks |
| Vaginal discharge | Watery, bloody, or white discharge not related to normal cycle | If persistent or foul-smelling |
| Urinary symptoms | Painful urination, difficulty urinating, or increased frequency | If accompanied by other symptoms |
| Unexplained weight loss | Weight loss without changes in diet or exercise | If significant and unexplained |
Risk Factors and Pathophysiology
Endometrioid carcinoma is often driven by estrogen stimulation without progesterone opposition. Key risk factors include:
- Obesity (BMI ≥30)
- Diabetes mellitus
- Hypertension
- Early menarche (before age 12)
- Late menopause (after age 55)
- Nulliparity (never having given birth)
- Tamoxifen use for breast cancer
- Family history of endometrial or colorectal cancer (Lynch syndrome)
Genetic predisposition, particularly Lynch syndrome, accounts for about 5% of cases. Testing for hereditary cancer syndromes using Next-Generation Sequencing (NGS) and Whole Exome Sequencing (WES) can identify mutations in genes such as MLH1, MSH2, MSH6, and PMS2.
Diagnostic Modalities and Genetic Testing
If symptoms suggest endometrioid carcinoma, the following diagnostic steps are recommended:
- Transvaginal ultrasound to assess endometrial thickness.
- Endometrial biopsy for histopathological confirmation.
- Genetic testing (NGS/WES) for hereditary cancer syndromes, especially if family history is suggestive.
DNA Labs India offers comprehensive genetic panels for hereditary gynecologic cancers, utilizing advanced NGS technology. As an ISO 9001 certified lab, we ensure accurate and reliable results.
When to Seek Medical Evaluation
Any postmenopausal bleeding is a red flag and requires immediate evaluation. Premenopausal women with persistent abnormal bleeding, pelvic pain, or other concerning symptoms should consult a gynecologist within two weeks. Early diagnosis significantly improves prognosis.
Prevention and Proactive Health
While some risk factors are non-modifiable, you can reduce your risk by:
- Maintaining a healthy weight through diet and exercise.
- Managing diabetes and hypertension.
- Discussing hormonal contraception with your doctor, as oral contraceptives and IUDs may lower risk.
- Undergoing regular gynecologic check-ups.
Frequently Asked Questions
Is endometrioid carcinoma hereditary?
Most cases are sporadic, but about 5% are linked to Lynch syndrome. Genetic testing can identify inherited mutations.
Can endometrioid carcinoma be detected early?
Yes, regular gynecologic exams and prompt evaluation of symptoms lead to early detection, which is highly treatable.